These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 1653630

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Altered topoisomerase I and II activities in suramin-resistant lung fibrosarcoma cells.
    Lelièvre S, Benchokroun Y, Larsen AK.
    Mol Pharmacol; 1995 May; 47(5):898-906. PubMed ID: 7746278
    [Abstract] [Full Text] [Related]

  • 23. Netropsin and bis-netropsin analogs as inhibitors of the catalytic activity of mammalian DNA topoisomerase II and topoisomerase cleavable complexes.
    Beerman TA, Woynarowski JM, Sigmund RD, Gawron LS, Rao KE, Lown JW.
    Biochim Biophys Acta; 1991 Aug 27; 1090(1):52-60. PubMed ID: 1653020
    [Abstract] [Full Text] [Related]

  • 24. DNA topoisomerase III from extremely thermophilic archaebacteria. ATP-independent type I topoisomerase from Desulfurococcus amylolyticus drives extensive unwinding of closed circular DNA at high temperature.
    Slesarev AI, Zaitzev DA, Kopylov VM, Stetter KO, Kozyavkin SA.
    J Biol Chem; 1991 Jul 05; 266(19):12321-8. PubMed ID: 1648092
    [Abstract] [Full Text] [Related]

  • 25. DNA topoisomerases as targets for the anticancer drug TAS-103: DNA interactions and topoisomerase catalytic inhibition.
    Fortune JM, Velea L, Graves DE, Utsugi T, Yamada Y, Osheroff N.
    Biochemistry; 1999 Nov 23; 38(47):15580-6. PubMed ID: 10569942
    [Abstract] [Full Text] [Related]

  • 26. Characterization of DNA topoisomerase activity in two strains of Mycoplasma fermentans and in Mycoplasma pirum.
    Horowitz S, Maor R, Priel E.
    J Bacteriol; 1997 Nov 23; 179(21):6626-32. PubMed ID: 9352909
    [Abstract] [Full Text] [Related]

  • 27. Interaction in vitro of type III intermediate filament proteins with supercoiled plasmid DNA and modulation of eukaryotic DNA topoisomerase I and II activities.
    Li G, Tolstonog GV, Sabasch M, Traub P.
    DNA Cell Biol; 2002 Oct 23; 21(10):743-69. PubMed ID: 12443544
    [Abstract] [Full Text] [Related]

  • 28. Rapid increase in the activity of DNA topoisomerase I, but not topoisomerase II, in HL-60 promyelocytic leukemia cells treated with a phorbol diester.
    Gorsky LD, Cross SM, Morin MJ.
    Cancer Commun; 1989 Oct 23; 1(2):83-92. PubMed ID: 2561736
    [Abstract] [Full Text] [Related]

  • 29. Phosphorylation of mammalian DNA topoisomerase I and activation by protein kinase C.
    Pommier Y, Kerrigan D, Hartman KD, Glazer RI.
    J Biol Chem; 1990 Jun 05; 265(16):9418-22. PubMed ID: 2160979
    [Abstract] [Full Text] [Related]

  • 30. Interactions of Drosophila DNA topoisomerase II with left-handed Z-DNA in supercoiled minicircles.
    Glikin GC, Jovin TM, Arndt-Jovin DJ.
    Nucleic Acids Res; 1991 Dec 05; 19(25):7139-44. PubMed ID: 1662808
    [Abstract] [Full Text] [Related]

  • 31. Effects of DNA topoisomerase inhibitors on nonhomologous and homologous recombination in mammalian cells.
    Aratani Y, Andoh T, Koyama H.
    Mutat Res; 1996 Feb 15; 362(2):181-91. PubMed ID: 8596537
    [Abstract] [Full Text] [Related]

  • 32. A human small cell lung carcinoma cell line, resistant to 4'-(9-acridinylamino)-methanesulfon-m-anisidide and cross-resistant to camptothecin with a high level of topoisomerase I.
    Prost S, Riou G.
    Biochem Pharmacol; 1994 Aug 30; 48(5):975-84. PubMed ID: 8093110
    [Abstract] [Full Text] [Related]

  • 33. Elongation by RNA polymerase II on chromatin templates requires topoisomerase activity.
    Mondal N, Zhang Y, Jonsson Z, Dhar SK, Kannapiran M, Parvin JD.
    Nucleic Acids Res; 2003 Sep 01; 31(17):5016-24. PubMed ID: 12930951
    [Abstract] [Full Text] [Related]

  • 34. Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemic cells selected for resistance to teniposide.
    Bugg BY, Danks MK, Beck WT, Suttle DP.
    Proc Natl Acad Sci U S A; 1991 Sep 01; 88(17):7654-8. PubMed ID: 1652758
    [Abstract] [Full Text] [Related]

  • 35. In vitro catenation and decatenation of DNA and a novel eucaryotic ATP-dependent topoisomerase.
    Baldi MI, Benedetti P, Mattoccia E, Tocchini-Valentini GP.
    Cell; 1980 Jun 01; 20(2):461-7. PubMed ID: 6248247
    [Abstract] [Full Text] [Related]

  • 36. Evodiamine, a dual catalytic inhibitor of type I and II topoisomerases, exhibits enhanced inhibition against camptothecin resistant cells.
    Pan X, Hartley JM, Hartley JA, White KN, Wang Z, Bligh SW.
    Phytomedicine; 2012 May 15; 19(7):618-24. PubMed ID: 22402246
    [Abstract] [Full Text] [Related]

  • 37. F 11782, a novel epipodophylloid non-intercalating dual catalytic inhibitor of topoisomerases I and II with an original mechanism of action.
    Perrin D, van Hille B, Barret JM, Kruczynski A, Etiévant C, Imbert T, Hill BT.
    Biochem Pharmacol; 2000 Apr 01; 59(7):807-19. PubMed ID: 10718339
    [Abstract] [Full Text] [Related]

  • 38. Topoisomerase-II activity in human leukemic and lymphoblastoid cells.
    Priel E, Aboud M, Feigelman H, Segal S.
    Biochem Biophys Res Commun; 1985 Jul 16; 130(1):325-32. PubMed ID: 2992464
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Identification of DNA topoisomerases involved in immediate and transient DNA relaxation induced by heat shock in Escherichia coli.
    Ogata Y, Mizushima T, Kataoka K, Miki T, Sekimizu K.
    Mol Gen Genet; 1994 Sep 01; 244(5):451-5. PubMed ID: 8078472
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.